Article

Symposium tackles difficult issues of glaucoma

Cardiovascular medicine has provided a road map that ophthalmology can follow in risk assessment.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(mage credit: Ophthalmology Times) S. Robert Levine, MD, on the DRD Cure Accelerator: A global moonshot for retinal disease
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
Related Content
(Image credit: Wills Eye Hospital) Wills Eye Hospital names Julia A. Haller, MD, as new chief executive officer
August 8th 2025

Wills Eye Hospital names Julia A. Haller, MD, as new chief executive officer

3 Things You Should Know About the GA Pipeline
August 8th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

(Image credit: AdobeStock/iQoncept) Q&A: Jeffrey L. Goldberg, MD, PhD, on the rise of clinical trials centers of excellence
August 8th 2025

Q&A: Jeffrey L. Goldberg, MD, PhD, on the rise of clinical trials centers of excellence

Patient-Centered Treatment Strategies in the Management of nAMD and DME
August 8th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

(Image credit: AdobeStock/Vitalii Vodolazskyi) Yale researchers identify corneal ulcer pathogens by testing tears
August 8th 2025

Yale researchers identify corneal ulcer pathogens by testing tears

(Image credit: Wilmer Eye Institute/Johns Hopkins Medicine)
August 8th 2025

Wilmer Eye Institute marks 100 years: honoring the past, shaping the future

© 2025 MJH Life Sciences

All rights reserved.